Nevro Raises $48M for Medical Devices

Nevro Corp., a medical device company focused on improving pain relief, has raised $48 million in Series C financing. New investor Novo Ventures led the round, and was joined by New Enterprise Associates and Covidien Ventures. Existing investors participating in this financing round included Accuitive Medical Ventures, Bay City Capital, Johnson & Johnson Development Corporation, Mayo Clinic, MPM Capital, and Three Arch Partners. Nevro is based in Menlo Park, Calif.

North AmericaUSBriefs